We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

76 hedge funds and large institutions have $58M invested in Akebia Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

484% more call options, than puts

Call options by funds: $1.61M | Put options by funds: $276K

26% more capital invested

Capital invested by funds: $46M → $58M (+$12M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.04% less ownership

Funds ownership: 27.05% → 27% (-0.04%)

10% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 21

4% less funds holding

Funds holding: 79 → 76 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
76
Holders Change
-3
Holders Change %
-3.8%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
19
Reduced
21
Closed
10
Calls
$1.61M
Puts
$276K
Net Calls
+$1.33M
Net Calls Change
+$646K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.34M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$546K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$479K
4
Citigroup
Citigroup
New York
+$196K
5
Bank of America
Bank of America
North Carolina
+$156K

Top Sellers

Rank Fund Capital Flow
1
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$404K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$372K
3
BlackRock
BlackRock
New York
-$364K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$304K
5
XT
XTX Topco
Cayman Islands
-$258K
Name Holding Trade Value Shares
Change 		Change in
Stake
Mackenzie Financial
51
Mackenzie Financial
Ontario, Canada
$17.7K -$13.3K -10,370 -38%
SC
52
Sykon Capital
New York
$17.1K – – –
Envestnet Asset Management
53
Envestnet Asset Management
Illinois
$16.3K +$352 +274 +2%
Baird Financial Group
54
Baird Financial Group
Wisconsin
$14.5K +$16.4K +12,743 New
OBWG
55
Onyx Bridge Wealth Group
New York
$14.3K – – –
Wells Fargo
56
Wells Fargo
California
$12.6K -$152 -118 -1%
RCM
57
RB Capital Management
Nevada
$11.4K – – –
SIMG
58
Sonora Investment Management Group
Arizona
$11.4K – – –
AAS
59
Ameritas Advisory Services
Nebraska
$10.5K – – –
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$10.1K +$212 +165 +2%
AF
61
Advisornet Financial
Minnesota
$5.7K – – –
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$5.62K – – –
PP
63
PrairieView Partners
Minnesota
$4K – – –
Fifth Third Bancorp
64
Fifth Third Bancorp
Ohio
$3.76K – – –
NA
65
NewEdge Advisors
Louisiana
$2.89K – – –
JFGIW
66
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$1.6K +$1.8K +1,400 New
TRCT
67
Tower Research Capital (TRC)
New York
$1.34K -$11.2K -8,694 -88%
TC
68
Truvestments Capital
Florida
$862 – – –
AF
69
Allworth Financial
California
$853 – – –
Osaic Holdings
70
Osaic Holdings
Arizona
$842 – – –
BWP
71
Baldwin Wealth Partners
Massachusetts
$640 – – –
HCP
72
Hexagon Capital Partners
Arkansas
$212 – – –
FDCDDQ
73
Federation des caisses Desjardins du Quebec
Quebec, Canada
$171 – – –
FWM
74
Focused Wealth Management
New York
$74 – – –
VF
75
Virtu Financial
New York
– -$46K -50,633 Closed
1 2
3
4

AKBA Hedge Fund Activity: Q3 2023 in Review

76 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q3 2023, worth a combined $58M — up 26% from $46M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AKBA and 7 opened new positions — a net loss of 3 holders — while 21 trimmed existing stakes and 19 added.

The largest buyer was Millennium Management, adding an estimated $1.34M. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $404K.

  • 76 institutional investors held Akebia Therapeutics (AKBA) as of Q3 2023, down from 79 in Q2 2023.
  • Funds reported $58M of Akebia Therapeutics stock for Q3 2023, up 26% quarter-over-quarter.
  • 7 funds opened new Akebia Therapeutics positions in Q3 2023 and 10 closed out, a net change of -3 holders.
  • The largest Akebia Therapeutics buyer in Q3 2023 was Millennium Management, an estimated $1.34M added.
  • The largest Akebia Therapeutics seller in Q3 2023 was Qube Research & Technologies (QRT), an estimated $404K sold.

Based on aggregated 13F filings for Q3 2023.